ProfileGDS5678 / 1422966_a_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 61% 62% 62% 62% 63% 63% 62% 62% 62% 62% 62% 62% 62% 62% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.7102661
GSM967853U87-EV human glioblastoma xenograft - Control 23.7149562
GSM967854U87-EV human glioblastoma xenograft - Control 33.7029362
GSM967855U87-EV human glioblastoma xenograft - Control 43.6667562
GSM967856U87-EV human glioblastoma xenograft - Control 53.7478263
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.8320663
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.8132662
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.709162
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.6977262
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.7089862
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.6980962
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.6851962
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.697362
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.7022562